<DOC>
	<DOCNO>NCT03083925</DOCNO>
	<brief_summary>To evaluate clinical benefit patient receive Viatorr CX period 12 month structure Follow-up ( TIPS , TIPS , 1 week TIPS , 6 week , 4 month , 6 month , 9 month , 12 month ) , regard clinical endpoint , HE , readmission , liver injury , cardiac function , response TIPS passive expansion stent real life .</brief_summary>
	<brief_title>Viatorr CX Case-control Study Complications Portal Hypertension</brief_title>
	<detailed_description>Case-control study use patient University Clinic Bonn receive Viatorr CX ( n=40 ) , use comparison ration 1:1:1 Viatorr bare metal stent . Of patient , 20 patient receive Viatorr CX assessement width stent outline JVIR-paper publish year . The Viatorr BMS control similar age , gender , Child , MELD indication TIPS . A total 125 patient primary composite-endpoint HE/readmission investigate Secondary endpoint liver injury , cardiac function , response TIPS passive expansion stent real life .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>Patients suitable TIPS Contraindication TIPS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>